Androgen composition for treating an opthalmic condition
AssigneeAllergan, Inc.
InventorsJohn T. Trogden, Adnan K. Salameh, Chetan P. Pujara, Anuradha V. Gore, Jaya Giyanani
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.
Claims28
An ophthalmic emulsion comprising testosterone in an amount of about 0.03 w/w % and castor oil in an amount of about 0.25 w/w %, wherein the emulsion is suitable for topical administration to an eye.
An ophthalmic emulsion comprising testosterone in an amount of about 0.1 w/w % and castor oil in an amount of about 0.25 w/w % wherein the emulsion is suitable for topical administration to an eye.
An ophthalmic emulsion comprising testosterone in an amount of about 0.3 w/w % and castor oil in an amount of about 0.25 w/w %, wherein the emulsion is suitable for topical administration to an eye.
Dependencies are inferred from the claim text.